Loading…

Device-assisted transdermal drug delivery

Transdermal drug delivery is a prospective drug delivery strategy to complement the limitations of conventional drug delivery systems including oral and injectable methods. This delivery route allows both convenient and painless drug delivery and a sustained release profile with reduced side effects...

Full description

Saved in:
Bibliographic Details
Published in:Advanced drug delivery reviews 2018-03, Vol.127, p.35-45
Main Authors: Lee, Hyunjae, Song, Changyeong, Baik, Seungmin, Kim, Dokyoon, Hyeon, Taeghwan, Kim, Dae-Hyeong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93
cites cdi_FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93
container_end_page 45
container_issue
container_start_page 35
container_title Advanced drug delivery reviews
container_volume 127
creator Lee, Hyunjae
Song, Changyeong
Baik, Seungmin
Kim, Dokyoon
Hyeon, Taeghwan
Kim, Dae-Hyeong
description Transdermal drug delivery is a prospective drug delivery strategy to complement the limitations of conventional drug delivery systems including oral and injectable methods. This delivery route allows both convenient and painless drug delivery and a sustained release profile with reduced side effects. However, physiological barriers in the skin undermine the delivery efficiency of conventional patches, limiting drug candidates to small-molecules and lipophilic drugs. Recently, transdermal drug delivery technology has advanced from unsophisticated methods simply relying on natural diffusion to drug releasing systems that dynamically respond to external stimuli. Furthermore, physical barriers in the skin have been overcome using microneedles, and controlled delivery by wearable biosensors has been enabled ultimately. In this review, we classify the evolution of advanced drug delivery strategies based on generations and provide a comprehensive overview. Finally, the recent progress in advanced diagnosis and therapy through customized drug delivery systems based on real-time analysis of physiological cues is highlighted. [Display omitted]
doi_str_mv 10.1016/j.addr.2017.08.009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1935399206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169409X17301801</els_id><sourcerecordid>1935399206</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EoqXwBxhQRxgSnp3EsSUWVD6lSiwgsVmO3wtylTbFTir135OqhZHpLude6R7GLjmkHLi8XaQWMaQCeJmCSgH0ERtzVYpECZ0fs_EA6SQH_TliZzEuALgoJZyykVBKlkLLMbt5oI13lNgYfewIp12wq4gUlraZYui_pkiN31DYnrOT2jaRLg45YR9Pj--zl2T-9vw6u58nLitkl5R1oREzoV2e87JwokJtC1UOIUEoi0qixSqvIbO55NwiVXUmpNBKS0E6m7Dr_e46tN89xc4sfXTUNHZFbR8N11mRaS1ADqjYoy60MQaqzTr4pQ1bw8HsFJmF2SkyO0UGlBkUDaWrw35fLQn_Kr9OBuBuD9DwcuMpmOg8rRyhD-Q6g63_b_8Hxg12yA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1935399206</pqid></control><display><type>article</type><title>Device-assisted transdermal drug delivery</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Lee, Hyunjae ; Song, Changyeong ; Baik, Seungmin ; Kim, Dokyoon ; Hyeon, Taeghwan ; Kim, Dae-Hyeong</creator><creatorcontrib>Lee, Hyunjae ; Song, Changyeong ; Baik, Seungmin ; Kim, Dokyoon ; Hyeon, Taeghwan ; Kim, Dae-Hyeong</creatorcontrib><description>Transdermal drug delivery is a prospective drug delivery strategy to complement the limitations of conventional drug delivery systems including oral and injectable methods. This delivery route allows both convenient and painless drug delivery and a sustained release profile with reduced side effects. However, physiological barriers in the skin undermine the delivery efficiency of conventional patches, limiting drug candidates to small-molecules and lipophilic drugs. Recently, transdermal drug delivery technology has advanced from unsophisticated methods simply relying on natural diffusion to drug releasing systems that dynamically respond to external stimuli. Furthermore, physical barriers in the skin have been overcome using microneedles, and controlled delivery by wearable biosensors has been enabled ultimately. In this review, we classify the evolution of advanced drug delivery strategies based on generations and provide a comprehensive overview. Finally, the recent progress in advanced diagnosis and therapy through customized drug delivery systems based on real-time analysis of physiological cues is highlighted. [Display omitted]</description><identifier>ISSN: 0169-409X</identifier><identifier>EISSN: 1872-8294</identifier><identifier>DOI: 10.1016/j.addr.2017.08.009</identifier><identifier>PMID: 28867296</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Controlled drug delivery ; Microneedles ; Soft bioelectronics ; Transdermal drug delivery ; Wearable biosensors</subject><ispartof>Advanced drug delivery reviews, 2018-03, Vol.127, p.35-45</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93</citedby><cites>FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93</cites><orcidid>0000-0003-1954-8124</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28867296$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Hyunjae</creatorcontrib><creatorcontrib>Song, Changyeong</creatorcontrib><creatorcontrib>Baik, Seungmin</creatorcontrib><creatorcontrib>Kim, Dokyoon</creatorcontrib><creatorcontrib>Hyeon, Taeghwan</creatorcontrib><creatorcontrib>Kim, Dae-Hyeong</creatorcontrib><title>Device-assisted transdermal drug delivery</title><title>Advanced drug delivery reviews</title><addtitle>Adv Drug Deliv Rev</addtitle><description>Transdermal drug delivery is a prospective drug delivery strategy to complement the limitations of conventional drug delivery systems including oral and injectable methods. This delivery route allows both convenient and painless drug delivery and a sustained release profile with reduced side effects. However, physiological barriers in the skin undermine the delivery efficiency of conventional patches, limiting drug candidates to small-molecules and lipophilic drugs. Recently, transdermal drug delivery technology has advanced from unsophisticated methods simply relying on natural diffusion to drug releasing systems that dynamically respond to external stimuli. Furthermore, physical barriers in the skin have been overcome using microneedles, and controlled delivery by wearable biosensors has been enabled ultimately. In this review, we classify the evolution of advanced drug delivery strategies based on generations and provide a comprehensive overview. Finally, the recent progress in advanced diagnosis and therapy through customized drug delivery systems based on real-time analysis of physiological cues is highlighted. [Display omitted]</description><subject>Controlled drug delivery</subject><subject>Microneedles</subject><subject>Soft bioelectronics</subject><subject>Transdermal drug delivery</subject><subject>Wearable biosensors</subject><issn>0169-409X</issn><issn>1872-8294</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAURS0EoqXwBxhQRxgSnp3EsSUWVD6lSiwgsVmO3wtylTbFTir135OqhZHpLude6R7GLjmkHLi8XaQWMaQCeJmCSgH0ERtzVYpECZ0fs_EA6SQH_TliZzEuALgoJZyykVBKlkLLMbt5oI13lNgYfewIp12wq4gUlraZYui_pkiN31DYnrOT2jaRLg45YR9Pj--zl2T-9vw6u58nLitkl5R1oREzoV2e87JwokJtC1UOIUEoi0qixSqvIbO55NwiVXUmpNBKS0E6m7Dr_e46tN89xc4sfXTUNHZFbR8N11mRaS1ADqjYoy60MQaqzTr4pQ1bw8HsFJmF2SkyO0UGlBkUDaWrw35fLQn_Kr9OBuBuD9DwcuMpmOg8rRyhD-Q6g63_b_8Hxg12yA</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Lee, Hyunjae</creator><creator>Song, Changyeong</creator><creator>Baik, Seungmin</creator><creator>Kim, Dokyoon</creator><creator>Hyeon, Taeghwan</creator><creator>Kim, Dae-Hyeong</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1954-8124</orcidid></search><sort><creationdate>20180301</creationdate><title>Device-assisted transdermal drug delivery</title><author>Lee, Hyunjae ; Song, Changyeong ; Baik, Seungmin ; Kim, Dokyoon ; Hyeon, Taeghwan ; Kim, Dae-Hyeong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Controlled drug delivery</topic><topic>Microneedles</topic><topic>Soft bioelectronics</topic><topic>Transdermal drug delivery</topic><topic>Wearable biosensors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Hyunjae</creatorcontrib><creatorcontrib>Song, Changyeong</creatorcontrib><creatorcontrib>Baik, Seungmin</creatorcontrib><creatorcontrib>Kim, Dokyoon</creatorcontrib><creatorcontrib>Hyeon, Taeghwan</creatorcontrib><creatorcontrib>Kim, Dae-Hyeong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advanced drug delivery reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Hyunjae</au><au>Song, Changyeong</au><au>Baik, Seungmin</au><au>Kim, Dokyoon</au><au>Hyeon, Taeghwan</au><au>Kim, Dae-Hyeong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Device-assisted transdermal drug delivery</atitle><jtitle>Advanced drug delivery reviews</jtitle><addtitle>Adv Drug Deliv Rev</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>127</volume><spage>35</spage><epage>45</epage><pages>35-45</pages><issn>0169-409X</issn><eissn>1872-8294</eissn><abstract>Transdermal drug delivery is a prospective drug delivery strategy to complement the limitations of conventional drug delivery systems including oral and injectable methods. This delivery route allows both convenient and painless drug delivery and a sustained release profile with reduced side effects. However, physiological barriers in the skin undermine the delivery efficiency of conventional patches, limiting drug candidates to small-molecules and lipophilic drugs. Recently, transdermal drug delivery technology has advanced from unsophisticated methods simply relying on natural diffusion to drug releasing systems that dynamically respond to external stimuli. Furthermore, physical barriers in the skin have been overcome using microneedles, and controlled delivery by wearable biosensors has been enabled ultimately. In this review, we classify the evolution of advanced drug delivery strategies based on generations and provide a comprehensive overview. Finally, the recent progress in advanced diagnosis and therapy through customized drug delivery systems based on real-time analysis of physiological cues is highlighted. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28867296</pmid><doi>10.1016/j.addr.2017.08.009</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1954-8124</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0169-409X
ispartof Advanced drug delivery reviews, 2018-03, Vol.127, p.35-45
issn 0169-409X
1872-8294
language eng
recordid cdi_proquest_miscellaneous_1935399206
source ScienceDirect Freedom Collection 2022-2024
subjects Controlled drug delivery
Microneedles
Soft bioelectronics
Transdermal drug delivery
Wearable biosensors
title Device-assisted transdermal drug delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Device-assisted%20transdermal%20drug%20delivery&rft.jtitle=Advanced%20drug%20delivery%20reviews&rft.au=Lee,%20Hyunjae&rft.date=2018-03-01&rft.volume=127&rft.spage=35&rft.epage=45&rft.pages=35-45&rft.issn=0169-409X&rft.eissn=1872-8294&rft_id=info:doi/10.1016/j.addr.2017.08.009&rft_dat=%3Cproquest_cross%3E1935399206%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-7f59dd329c44175c2bd9a587bd96028ad86dadb4f03a4611adebf326298962e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1935399206&rft_id=info:pmid/28867296&rfr_iscdi=true